An international, multicenter, prospective survey has been conducted to determine the hospital survival rates of patients with potentially reversible acute respiratory failure (ARF) who are managed in sophisticated intensive care units by leading critical care specialists, using current (1991 to 1992) support and treatment techniques and protocols. Twenty-five clinical centers participated in the survey, 11 in the United States and 14 in Europe. A total of 1,426 patients with ARF were studied, all of whom had been receiving closed system positive pressure mechanical ventilation at an FIo2 of at least 0.50 for at least 24 h at the time of entry into the survey. Of the survey patients, 793 (55.6%) survived their hospitalization, while 633 (44.4%) died in the hospital. The 1,426 patients with ARF were prospectively divided into two groups: group A, containing 375 patients, who at the time of entry into the study were hypoxemic or hypercarbic while receiving mechanical ventilator assistance; and group B, containing 1,051 patients, who at the time of entry into the study were neither hypoxemic nor hypercarbic while receiving mechanical ventilator support at an F1o2 of 0.50 or greater. Hospital survival rate for group A patients was 33.3% and for group B patients it was 63.6%. Survival rates were higher in patients with ARF caused by pneumonia (63%) or post shock lung injury (67%) and lower in patients with ARF caused by sepsis (46%). Severity of lung injury at the time of entry into the survey was a major prognostic factor, varying from an 18% hospital survival rate for patients with ARF with far advanced lung injury to a survival rate of 67% for patients with ARF with less severe lung injury. Low survival rates (<20%) were seen if mechanical ventilator FIo2 was 0.80 to 1.0, while 50% of the patients with ARF survived hospitalization whose FIo2 at entry was 0.50. Peak inspiratory pressure (PIP) >50 cm H20
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The poor prognosis of patients with severe, but potentially reversible, acute respiratory failure (ARF) has long been recognized. Reports describing hospital survival rates for such patients from as low as 9% to as high as 50% have appeared in medical (Table 3) .
Group B patients (who had acceptable blood gas values on only moderately intense mechanical ventilation) had hospital survival rates of 64% (or mortality rates of 36%) when supported by current protocols for control of mechanical ventilator control settings (Table 4) . When patients were hypoxemic or hypercarbic while receiving moderate mechanical ventilator support, requiring upward adjustment of ventilator settings to achieve acceptable blood gas values, the hospital survival rate was low (33.3%).
Considering etiology of the ARF in patients surveyed, the data indicate that patients in group A with pneumonia or pneumonitis had the lowest hospital survival rate (28.5%), followed by ARF due to sepsis (30.1%); patients with ARF caused by postshock lung injury (usually trauma or postsurgical cases) had the best hospital survival rate (46.4%) ( Table 5 ). Among the less ill, group B patients, those with sepsis-induced ARF had the lowest hospital survival rate (46.4%), while the best hospital survival rate (67.5%) was found in patients with ARF caused by postshock lung injury. When Group A patients are segregated according to the severity of their lung dysfunction at the time of entry into the survey (using the composite Murray Lung Injury Score1 to separate the patients), there is a major increase in hospital survival rates as the severity of the lung dysfunction decreases-from 18.4% in patients with far-advanced lung disease, to 66.7% for patients with less severe lung injury (Table 6 ).
Essentially the same hospital survival rates were found when the oxygenation index (PaO2/FIo2) is used as the indicator of severity of lung dysfunction (Table 6) .
Another prognostic factor investigated was the intensity of mechanical ventilator support the patient was receiving when the criteria for inclusion into group A were met. The higher the FIo2, the peak inspiratory pressure (PIP), and/or the minute volume delivered by the ventilator, the lower the hospital survival rate. The relationship of intensity of positive end-expiratory pressure with hospital survival was less noticeable than was that of the other ventilator settings (Fig 1) . These data indicate that hospital survival rates are less in patients with ARF who require FIo2 over 0.70, PIP greater than 40 cm H20, and minute volume greater than 15 L/min.
It was found that the more hypoxemic the patient at the time of entry into the survey, the lower the hospital survival rate (Fig 2) . The extent of deviation from normal PaCO2 at the time of entry had no consistent correlation with hospital survival rate.
Duration of tracheal intubation and positive pressure mechanical ventilator support prior to qualification for inclusion in group A appeared to have an inverse influence on hospital survival rates, so that shorter times of mechanical ventilation were associated with higher hospital survival rates; and patients with longer periods of preentry mechanical ventilation had lower hospital survival rates. Thus, hospital survival rates for patients with ARF who had received mechanical ventilation for less than 48 h before entering the survey was 38%, while it was 30% for those receiving mechanical ventilatory assistance for more than 2 weeks before entering the survey.
Multiorgan dysfunction in patients with ARF was associated with low hospital survival rates (Table 7) . with pulmonary system dysfunction alone was 45%, while group A patients with two system dysfunction was 16% and for those with three or more systems dysfunction was only 10%. Demographic parameters of gender, age of patient, and body weight appeared to have little or no influence on hospital survival rates of group A patients.
DISCUSSION
The primary finding from this survey indicates that hospital survival rates for patients with ARF receiving mechanical ventilator support at moderate to high levels of intensity are no better today in highly sophisticated respiratory ICUs than they were 10 to 20 years ago, despite significant advances in techniques for respiratory care. This observation has been reported by several authors9'11 but has been challenged by others. 8, 12 This unsatisfactory circumstance suggests that critical evaluation of standard accepted methods for management of patients in advanced ARF is warranted.
Most (73.7%) patients with ARF surveyed achieved acceptable blood gas values with mechanical venti- suggest that critical care clinicians should consider patients with ARF who require mechanical ventilation with FIo2 of 0.50 or greater (or minute volume through the ventilator of 15 L/min or more) to achieve acceptable blood gas values to be in advanced stages of lung injury, with poor prognosis. The data indicating an inverse relationship between severity of lung injury and hospital survival rates provide firm support for the often expressed intuitive opinion that hospital survival of patients with ARF is most closely related to the severity of the lung injury.
Not unexpectedly, this survey demonstrated that the higher the intensity of mechanical ventilator support received by patients with ARF (FIo2, PIP, and minute volume delivered by the ventilator), the lower the hospital survival rate. A rather obvious conclusion is that, if possible, the attending physician should seriously attempt to utilize mechanical ventilation at the lowest effective levels of intensity. However, the finding that the more hypoxemic the 
CONCLUSIONS
In 1991 to 1992, management of patients in severe ARF, regardless of the primary cause, remains a serious problem for the intensivist.
Hospital survival rates for patients with ARF who require positive pressure mechanical ventilation at or above generally accepted maximum safe levels of intensity remain discouragingly low (between 33 and 63%) when blood gas transfer is augmented by mechanical ventilator alone. Current hospital survival rates for patients in severe ARF appear to be essentially the same as for similar patients cared for 10 to 20 years ago.
Currently, the most important predictors of hospital survival rates of patients in ARF supported by mechanical ventilation are as follows: (1) severity of lung dysfunction; (2) etiology of the ARF; (3) intensity of mechanical ventilation required to achieve acceptable blood gas values; (4) existence and severity of hypoxemia when the patient is receiving maximum safe ventilator support; (5) duration of mechanical ventilation before patient shows significant improvement in natural lung function; and (6) existence of multiorgan dysfunction in patients with ARF.
